London’s Unravel Health raises €2.96 million to help women track hormones at home with a palm-sized lab
London-based Unravel Health raised €2.96 million to develop a palm-sized at-home hormone testing device, led by Conduit EIS Impact Fund and Wrightwood. The round shows continued investor interest in European hardware-based medtech diagnostics for consumer health.